Home/Filings/4/0001209191-21-040333
4//SEC Filing

GUETH ANTON 4

Accession 0001209191-21-040333

CIK 0001016169other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 6:23 PM ET

Size

9.1 KB

Accession

0001209191-21-040333

Insider Transaction Report

Form 4
Period: 2021-06-10
GUETH ANTON
Director
Transactions
  • Award

    Common Stock

    2021-06-10$4.42/sh+25,452$112,498567,577 total
  • Award

    Stock Option (right to buy)

    2021-06-10+48,54248,542 total
    Exercise: $4.42Exp: 2031-06-10Common Stock (48,542 underlying)
Footnotes (3)
  • [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date. The reporting person has elected to defer the receipt of shares until separation of service as a Director.
  • [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
  • [F3]The options vest and become exercisable one year from the grant date.

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeother

Related Parties

1
  • filerCIK 0001274940

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:23 PM ET
Size
9.1 KB